Research on Alzheimer’s disease (AD) has recently begun to expand in the scope of variables considered in examining prevalence worldwide; many scientists argue prevalence is related to geographic distribution of its major symptom, dementia. For this reason, I researched the components of AD and their specific effects on the regional trends of dementia. Evidence from eight peer-reviewed journal articles authored by both neurologists and environmental scientists reveals that researchers argue either the environmental or genetic effects of location on dementia prevalence. However, it appears the regional bias for the disease seen worldwide is caused by a combination of environmental and genetic factors. A singular factor of AD cases varies amo...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
OBJECTIVE: To determine whether differences in genetic origin affect the clinical course of Alzheime...
The global prevalence of dementia has been estimated to be as high as 24 million, and is predicted t...
environmental Advances in molecular genetics have revolutionizedepidemiologic research. Epidemiologi...
The global prevalence of dementia has been estimated to be as high as 24 million, and is pre-dicted ...
Dementia, especially Alzheimer’s dementia, which occupies more than 60% of total dementia cases, has...
The global prevalence of dementia has been estimated to be as high as 24 million, and is pre-dicted ...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
The prevalence of dementia varies substantially worldwide. This is partially attributed to the lack ...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
OBJECTIVE: To determine whether differences in genetic origin affect the clinical course of Alzheime...
The global prevalence of dementia has been estimated to be as high as 24 million, and is predicted t...
environmental Advances in molecular genetics have revolutionizedepidemiologic research. Epidemiologi...
The global prevalence of dementia has been estimated to be as high as 24 million, and is pre-dicted ...
Dementia, especially Alzheimer’s dementia, which occupies more than 60% of total dementia cases, has...
The global prevalence of dementia has been estimated to be as high as 24 million, and is pre-dicted ...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
Ageing and genetic traits can only explain the increasing dementia incidence partially. Advanced hea...
Our understanding of the epidemiology of Alzheimer disease (AD) has advanced rapidly during the past...
The prevalence of dementia varies substantially worldwide. This is partially attributed to the lack ...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its pr...
OBJECTIVE: To determine whether differences in genetic origin affect the clinical course of Alzheime...